The effects of the angiotensin II receptor (type I) antagonist irbesartan in patients with cardiac syndrome X

Heart. 2007 Feb;93(2):253-4. doi: 10.1136/hrt.2006.089904.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Biphenyl Compounds / therapeutic use*
  • Double-Blind Method
  • Drug Administration Schedule
  • Electrocardiography, Ambulatory
  • Female
  • Humans
  • Irbesartan
  • Male
  • Microvascular Angina / drug therapy*
  • Microvascular Angina / physiopathology
  • Middle Aged
  • Tetrazoles / therapeutic use*
  • Treatment Outcome

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Biphenyl Compounds
  • Tetrazoles
  • Irbesartan